Anti-L3MBTL3 Antibody

L3MBTL3 (Lethal(3) Malignant Brain Tumor-Like Protein 3) is a chromatin-associated polycomb group reader protein that recognizes methylated histone lysine residues through its MBT domains, contributing to transcriptional repression, chromatin compaction, and DNA damage response pathways. This unconjugated rabbit polyclonal reagent from Antibodies.com is raised against L3MBTL3 and validated for Western blot, immunohistochemistry, and immunofluorescence workflows in human samples, supporting studies of epigenetic regulation, hematopoiesis, and tumor biology. The antibody is supplied as 100 µl of a 1 mg/ml stock in PBS with 0.1% sodium azide and 50% glycerol as a stabilizing cryoprotectant, allowing direct dilution into standard blocking and incubation protocols. Polyclonal reactivity expands epitope coverage across the target, and the unconjugated format gives researchers flexibility to pair the reagent with HRP, biotin, fluorophore, or gold secondary conjugates suited to their chosen detection platform.